Effects of pulsed electromagnetic fields on the mRNA expression of CAII and RANK in ovariectomized rats

Rheumatol Int. 2012 Jun;32(6):1527-32. doi: 10.1007/s00296-010-1740-7. Epub 2011 Feb 15.

Abstract

The present study was designed to determine the effects of pulsed electromagnetic fields (PEMFs) on the mRNA expression of the carbonic anhydrase II (CAII) and receptor activator of NF-κB (RANK) in ovariectomized rats. A total of 48 SD rats were randomly divided into four groups [Sham, OVX, PEMFs, and E(2) (premarin)], 12 rats in each group. Rats in the Sham group received sham ovariectomy, while rats in OVX, PEMFs, and E(2) groups received ovariectomy. Twelve weeks following the surgery, rats (whole body) in the PEMFs group were exposed to PEMFs for 30 days with 3.8 mT, 8 Hz, and 40 min per day; rats in the E(2) group were administered premarin (0.0625 mg/kg/d; intragastric administration 1-2 ml/100 g). Rats in the Sham and OVX groups housed in the same conditions. At the end of intervention, the level of serum estradiol of rats was measured. The gene expression of CAII and RANK in the left ilium of rats was determined with real-time fluorescent-nested quantitative polymerase chain reaction. Compared with the Sham group, the level of serum estradiol in the ovariectomized group was significantly decreased (P < 0.05); compared with the OVX group, CAIImRNA expression was significantly decreased in the PEMFs group and E group (P < 0.05, 0.01, respectively). Compared with the E group, RANKmRNA expression was significantly higher in the PEMFs group (P < 0.05); although RANKmRNA expression decreased in PEMFs group, no statistically significant difference was found between PEMF group and OVX group (P = 0.82). These data suggest that PEMFs could regulate the expression of CAIImRNA in ovariectomized rats.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Carbonic Anhydrase II / genetics*
  • Electromagnetic Fields*
  • Estradiol / administration & dosage
  • Estradiol / blood
  • Estrogen Replacement Therapy
  • Estrogens / administration & dosage
  • Estrogens / blood
  • Estrogens, Conjugated (USP) / administration & dosage
  • Estrogens, Conjugated (USP) / blood
  • Female
  • Gene Expression Regulation, Enzymologic
  • Ilium / drug effects
  • Ilium / enzymology*
  • Ovariectomy*
  • RNA, Messenger / metabolism*
  • Rats
  • Rats, Sprague-Dawley
  • Real-Time Polymerase Chain Reaction
  • Receptor Activator of Nuclear Factor-kappa B / genetics*
  • Reverse Transcriptase Polymerase Chain Reaction
  • Time Factors

Substances

  • Estrogens
  • Estrogens, Conjugated (USP)
  • RNA, Messenger
  • Receptor Activator of Nuclear Factor-kappa B
  • Estradiol
  • Carbonic Anhydrase II